Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Artificial ...

The prognosis for non-small cell lung cancer (NSCLC) can depend on several factors, including the stage of your disease. Survival rates also vary.

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

He was posthumously diagnosed with metastatic pulmonary adenocarcinoma - lung cancer that had spread to the area of his chest between the lungs.

Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract.